Telehealth companies selling compounded drugs are making modest inroads into the market for popular weight loss drugs that Big Pharma spent ...

Can a weekly injection really help you shed weight? Dermatologist Dr Nivedita Dadu says “yes” and shares how she lost 14 kgs ...

Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

The clinical trial underscores Innovent’s ambition to deliver innovative obesity treatment to patients across Asia.

Compounded semaglutide and tirzepatide are untested and unregulated. Here’s what to discuss with your provider about taking these weight loss drugs.

Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels while also supporting weight reduction—positioning it for potential use in t ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...